Justiina Huhtakangas1, Hanna Lehto2, Karri Seppä2, Riku Kivisaari2, Mika Niemelä2, Juha Hernesniemi2, Martin Lehecka2. 1. From the Department of Neurosurgery, Helsinki University Hospital, University of Helsinki, Helsinki, Finland (J.H., H.L., R.K., M.N., J.H., M.L.); and Finnish Cancer Registry, Helsinki, Finland (K.S.). justiina.huhtakangas@hus.fi. 2. From the Department of Neurosurgery, Helsinki University Hospital, University of Helsinki, Helsinki, Finland (J.H., H.L., R.K., M.N., J.H., M.L.); and Finnish Cancer Registry, Helsinki, Finland (K.S.).
Abstract
BACKGROUND AND PURPOSE: There is high case-fatality rate and loss of productive life-years related to aneurysmal subarachnoid hemorrhage (aSAH) but data on long-term survival of patients with aSAH are scarce. We aim to evaluate long-term excess mortality and related risk factors after an aSAH event. METHODS: Survivors (n=3078) of aSAH who had survived for ≥1 year were reviewed for this retrospective follow-up study, which was conducted in the Department of Neurosurgery in Helsinki between 1980 and 2007. Follow-up started 1 year after the aSAH and continued until death or the end of 2012 (48 918 patient-years). Mortality and relative survival ratios were derived using a matched general population. RESULTS: Survivors of aSAH after 20 years showed 17% excess mortality compared with the general population. Even young patients and patients with good recovery showed excess mortality. The highest excess mortality was among patients with multiple aneurysms, old age, poor preoperative clinical condition, conservative aneurysm treatment, and unfavorable clinical outcome at 1 year. CONCLUSIONS: Even after initially favorable recovery from an aSAH, survivors experience excess mortality in the long run in comparison to a matched general population. Cardiovascular disease at younger age and cerebrovascular events were overrepresented as causes of death, which indicates the importance of treatment of vascular risk factors. Young patients and patients with multiple aneurysms who are recovering from an aSAH should be followed-up and treated most actively.
BACKGROUND AND PURPOSE: There is high case-fatality rate and loss of productive life-years related to aneurysmal subarachnoid hemorrhage (aSAH) but data on long-term survival of patients with aSAH are scarce. We aim to evaluate long-term excess mortality and related risk factors after an aSAH event. METHODS: Survivors (n=3078) of aSAH who had survived for ≥1 year were reviewed for this retrospective follow-up study, which was conducted in the Department of Neurosurgery in Helsinki between 1980 and 2007. Follow-up started 1 year after the aSAH and continued until death or the end of 2012 (48 918 patient-years). Mortality and relative survival ratios were derived using a matched general population. RESULTS: Survivors of aSAH after 20 years showed 17% excess mortality compared with the general population. Even young patients and patients with good recovery showed excess mortality. The highest excess mortality was among patients with multiple aneurysms, old age, poor preoperative clinical condition, conservative aneurysm treatment, and unfavorable clinical outcome at 1 year. CONCLUSIONS: Even after initially favorable recovery from an aSAH, survivors experience excess mortality in the long run in comparison to a matched general population. Cardiovascular disease at younger age and cerebrovascular events were overrepresented as causes of death, which indicates the importance of treatment of vascular risk factors. Young patients and patients with multiple aneurysms who are recovering from an aSAH should be followed-up and treated most actively.
Authors: Merel Sanne Ekker; Jamie Inge Verhoeven; Ilonca Vaartjes; Wilhelmus Martinus Tim Jolink; Catharina Johanna Maria Klijn; Frank-Erik de Leeuw Journal: JAMA Date: 2019-06-04 Impact factor: 56.272
Authors: Jorge A Roa; Mario Zanaty; Daizo Ishii; Yongjun Lu; David K Kung; Robert M Starke; James C Torner; Pascal M Jabbour; Edgar A Samaniego; David M Hasan Journal: J Neurosurg Date: 2020-03-06 Impact factor: 5.115
Authors: Chuanyuan Tao; Chaofeng Fan; Xin Hu; Junpeng Ma; Lu Ma; Hao Li; Yi Liu; Hong Sun; Min He; Chao You Journal: Medicine (Baltimore) Date: 2016-12 Impact factor: 1.889
Authors: Jukka Huttunen; Antti Lindgren; Mitja I Kurki; Terhi Huttunen; Juhana Frösen; Timo Koivisto; Mikael von Und Zu Fraunberg; Arto Immonen; Juha E Jääskeläinen; Reetta Kälviäinen Journal: Neurology Date: 2017-06-14 Impact factor: 9.910